Literature DB >> 27792908

Associations among plasma metabolite levels and short-term exposure to PM2.5 and ozone in a cardiac catheterization cohort.

Susanne Breitner1, Alexandra Schneider2, Robert B Devlin3, Cavin K Ward-Caviness4, David Diaz-Sanchez3, Lucas M Neas3, Wayne E Cascio3, Annette Peters2, Elizabeth R Hauser5, Svati H Shah5, William E Kraus5.   

Abstract

RATIONALE: Exposure to ambient particulate matter (PM) and ozone has been associated with cardiovascular disease (CVD). However, the mechanisms linking PM and ozone exposure to CVD remain poorly understood.
OBJECTIVE: This study explored associations between short-term exposures to PM with a diameter <2.5μm (PM2.5) and ozone with plasma metabolite concentrations. METHODS AND
RESULTS: We used cross-sectional data from a cardiac catheterization cohort at Duke University, North Carolina (NC), USA, accumulated between 2001 and 2007. Amino acids, acylcarnitines, ketones and total non-esterified fatty acid plasma concentrations were determined in fasting samples. Daily concentrations of PM2.5 and ozone were obtained from a Bayesian space-time hierarchical model, matched to each patient's residential address. Ten metabolites were selected for the analysis based on quality criteria and cluster analysis. Associations between metabolites and PM2.5 or ozone were analyzed using linear regression models adjusting for long-term trend and seasonality, calendar effects, meteorological parameters, and participant characteristics. We found delayed associations between PM2.5 or ozone and changes in metabolite levels of the glycine-ornithine-arginine metabolic axis and incomplete fatty acid oxidation associated with mitochondrial dysfunction. The strongest association was seen for an increase of 8.1μg/m3 in PM2.5 with a lag of one day and decreased mean glycine concentrations (-2.5% [95% confidence interval: -3.8%; -1.2%]).
CONCLUSIONS: Short-term exposures to ambient PM2.5 and ozone is associated with changes in plasma concentrations of metabolites in a cohort of cardiac catheterization patients. Our findings might help to understand the link between air pollution and cardiovascular disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Metabolomics; Ozone; Particulate matter

Mesh:

Substances:

Year:  2016        PMID: 27792908     DOI: 10.1016/j.envint.2016.10.012

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  17 in total

1.  Use of high-resolution metabolomics for the identification of metabolic signals associated with traffic-related air pollution.

Authors:  Donghai Liang; Jennifer L Moutinho; Rachel Golan; Tianwei Yu; Chandresh N Ladva; Megan Niedzwiecki; Douglas I Walker; Stefanie Ebelt Sarnat; Howard H Chang; Roby Greenwald; Dean P Jones; Armistead G Russell; Jeremy A Sarnat
Journal:  Environ Int       Date:  2018-08-07       Impact factor: 9.621

2.  Child serum metabolome and traffic-related air pollution exposure in pregnancy.

Authors:  Beate Ritz; Qi Yan; Di He; Jun Wu; Douglas I Walker; Karan Uppal; Dean P Jones; Julia E Heck
Journal:  Environ Res       Date:  2021-08-19       Impact factor: 6.498

3.  Effects of ambient ozone exposure on circulating extracellular vehicle microRNA levels in coronary artery disease patients.

Authors:  Hao Chen; Yunan Xu; Ana Rappold; David Diaz-Sanchez; Haiyan Tong
Journal:  J Toxicol Environ Health A       Date:  2020-05-15

4.  Health benefit assessment of PM2.5 reduction in Pearl River Delta region of China using a model-monitor data fusion approach.

Authors:  Jiabin Li; Yun Zhu; James T Kelly; Carey J Jang; Shuxiao Wang; Adel Hanna; Jia Xing; Che-Jen Lin; Shicheng Long; Lian Yu
Journal:  J Environ Manage       Date:  2018-12-26       Impact factor: 6.789

5.  Ambient and Traffic-Related Air Pollution Exposures as Novel Risk Factors for Metabolic Dysfunction and Type 2 Diabetes.

Authors:  Tanya L Alderete; Zhanghua Chen; Claudia M Toledo-Corral; Zuelma A Contreras; Jeniffer S Kim; Rima Habre; Leda Chatzi; Theresa Bastain; Carrie V Breton; Frank D Gilliland
Journal:  Curr Epidemiol Rep       Date:  2018-04-10

Review 6.  Application of metabolomics to characterize environmental pollutant toxicity and disease risks.

Authors:  Pan Deng; Xusheng Li; Michael C Petriello; Chunyan Wang; Andrew J Morris; Bernhard Hennig
Journal:  Rev Environ Health       Date:  2019-09-25       Impact factor: 4.022

7.  Ambient PM2.5 species and ultrafine particle exposure and their differential metabolomic signatures.

Authors:  Feiby L Nassan; Cuicui Wang; Rachel S Kelly; Jessica A Lasky-Su; Pantel S Vokonas; Petros Koutrakis; Joel D Schwartz
Journal:  Environ Int       Date:  2021-02-24       Impact factor: 13.352

8.  Extracellular vesicles enclosed-miR-421 suppresses air pollution (PM2.5 )-induced cardiac dysfunction via ACE2 signalling.

Authors:  Hongyun Wang; Tianhui Wang; Wei Rui; Jinxin Xie; Yuling Xie; Xiao Zhang; Longfei Guan; Guoping Li; Zhiyong Lei; Raymond M Schiffelers; Joost P G Sluijter; Junjie Xiao
Journal:  J Extracell Vesicles       Date:  2022-05

Review 9.  The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk.

Authors:  Matthew Nayor; Kemar J Brown; Ramachandran S Vasan
Journal:  Circ Res       Date:  2021-01-21       Impact factor: 17.367

10.  Metabolomic signatures of the short-term exposure to air pollution and temperature.

Authors:  Feiby L Nassan; Rachel S Kelly; Petros Koutrakis; Pantel S Vokonas; Jessica A Lasky-Su; Joel D Schwartz
Journal:  Environ Res       Date:  2021-06-24       Impact factor: 8.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.